Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Res Vet Sci ; 128: 308-314, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31901569

ABSTRACT

As most pathogens invade the bodies through the mucosa, it is crucial to develop vaccines that induce mucosal immunity. To this end, we generated a safe and effective vaccine candidate that displayed fimbrial protein 987P of enterotoxigenic Escherichia coli (ETEC) on the surface of Lactobacillus casei (L.casei) CICC 6105 by using poly-γ-glutamate synthetase A (PgsA) as an anchoring matrix. After gavage inoculation of the recombinant strain pLA-987P/L.casei into specific-pathogen-free (SPF) BALB/c mice, high levels of mucosal immunoglobulin A (IgA) were induced in fecal samples, intestine and lung lavage fluids and systemic immunoglobulin G of IgG subclasses (IgG1, IgG2b, and IgG2a) was produced in serum. T-cell proliferation assays showed the stimulation index (SI) of the groups immunized with pLA-987P/L.casei to be significantly higher than that of the control group. The recombinant L.casei promoted T cells to produce both Th1 and Th2 cytokines, while the number of splenic IL-4 Spot forming cells (SFC) exceeded the number of IFN-γ SFC by 2.26-fold (P < .01). >83.3% of the vaccinated mice were protected from challenge with a lethal dose of virulent strain C83916. These results indicate that the recombinant L.casei expressing ETEC 987P fimbrial protein could elicit a protective immune response against ETEC 987P infection effectively.


Subject(s)
Adhesins, Escherichia coli/immunology , Enterotoxigenic Escherichia coli/immunology , Escherichia coli Vaccines/biosynthesis , Fimbriae Proteins/immunology , Lacticaseibacillus casei/immunology , Microorganisms, Genetically-Modified/immunology , Adhesins, Escherichia coli/genetics , Administration, Oral , Animals , Antigens, Heterophile , Escherichia coli Proteins/genetics , Escherichia coli Proteins/immunology , Escherichia coli Vaccines/immunology , Fimbriae Proteins/genetics , Immunity, Humoral , Immunity, Mucosal , Immunogenicity, Vaccine , Lacticaseibacillus casei/genetics , Mice , Mice, Inbred BALB C , Transformation, Bacterial/genetics , Transformation, Bacterial/immunology , Vaccination/methods
2.
Infect Immun ; 84(6): 1887-1901, 2016 06.
Article in English | MEDLINE | ID: mdl-27068094

ABSTRACT

Natural genetic transformation of Streptococcus pneumoniae, an important human pathogen, mediates horizontal gene transfer for the development of drug resistance, modulation of carriage and virulence traits, and evasion of host immunity. Transformation frequency differs greatly among pneumococcal clinical isolates, but the molecular basis and biological importance of this interstrain variability remain unclear. In this study, we characterized the transformation frequency and other associated phenotypes of 208 S. pneumoniae clinical isolates representing at least 30 serotypes. While the vast majority of these isolates (94.7%) were transformable, the transformation frequency differed by up to 5 orders of magnitude between the least and most transformable isolates. The strain-to-strain differences in transformation frequency were observed among many isolates producing the same capsule types, indicating no general association between transformation frequency and serotype. However, a statistically significant association was observed between the levels of transformation and colonization fitness/virulence in the hypertransformable isolates. Although nontransformable mutants of all the selected hypertransformable isolates were significantly attenuated in colonization fitness and virulence in mouse infection models, such mutants of the strains with relatively low transformability had no or marginal fitness phenotypes under the same experimental settings. This finding strongly suggests that the pneumococci with high transformation capability are "addicted" to a "hypertransformable" state for optimal fitness in the human host. This work has thus provided an intriguing hint for further investigation into how the competence system impacts the fitness, virulence, and other transformation-associated traits of this important human pathogen.


Subject(s)
Gene Expression Regulation, Bacterial , Genes, Bacterial/immunology , Immune Evasion/genetics , Pneumonia, Pneumococcal/immunology , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/pathogenicity , Transformation, Bacterial/immunology , Animals , Disease Models, Animal , Female , Gene Expression Profiling , Genetic Fitness , Genetic Heterogeneity , Humans , Mice , Mice, Inbred BALB C , Nasopharynx/immunology , Nasopharynx/microbiology , Phenotype , Pneumonia, Pneumococcal/microbiology , Pneumonia, Pneumococcal/pathology , Serogroup , Streptococcus pneumoniae/immunology , Virulence
3.
Trends Microbiol ; 21(10): 516-21, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24021553

ABSTRACT

Bacteria are constantly challenged by foreign genetic elements such as bacteriophages and plasmids. Several defense systems provide immunity against such attackers, including restriction-modification (R-M) systems and clustered, regularly interspaced short palindromic repeats (CRISPRs). These systems target attacking DNA and thus antagonize natural transformation, which relies on uptake of exogenous DNA to promote acquisition of new genetic traits. It is unclear how this antagonization occurs, because transforming DNA is single stranded, and thus resistant to these immune systems. Here, we propose a simple model whereby these systems limit transformation by attack of transformed chromosomes once double strandedness is restored by chromosomal replication.


Subject(s)
Bacteria/immunology , Clustered Regularly Interspaced Short Palindromic Repeats/immunology , Transformation, Bacterial/immunology , Bacteria/genetics , Bacteriophages/genetics , Bacteriophages/immunology , Clustered Regularly Interspaced Short Palindromic Repeats/genetics , DNA/immunology , Plasmids , Transformation, Bacterial/genetics
4.
Acta Microbiol Immunol Hung ; 58(1): 13-22, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21450551

ABSTRACT

Mycobacterium smegmatis is a species of rapidly growing saprophytes with a number of properties that make it an effective vaccine vector. Recombinant M. smegmatis expressing protective antigens of different pathogens and molecules modulating the immune responses offers some potential for reduction of the burden of tuberculosis, HIV and hepatitis B infections. This paper discusses the molecular methods used to generate recombinant M. smegmatis and the results obtained with some of these recombinants.


Subject(s)
Mycobacterium smegmatis/genetics , Mycobacterium smegmatis/immunology , Transformation, Bacterial/genetics , Transformation, Bacterial/immunology , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Animals , Antigens, Bacterial/biosynthesis , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , HIV Antigens/biosynthesis , HIV Antigens/genetics , HIV Antigens/immunology , Humans
5.
PLoS Pathog ; 3(6): e81, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17559304

ABSTRACT

The environmental reservoirs for Vibrio cholerae are natural aquatic habitats, where it colonizes the chitinous exoskeletons of copepod molts. Growth of V. cholerae on a chitin surface induces competence for natural transformation, a mechanism for intra-species gene exchange. The antigenically diverse O-serogroup determinants of V. cholerae are encoded by a genetically variable biosynthetic cluster of genes that is flanked on either side by chromosomal regions that are conserved between different serogroups. To determine whether this genomic motif and chitin-induced natural transformation might enable the exchange of serogroup-specific gene clusters between different O serogroups of V. cholerae, a strain of V. cholerae O1 El Tor was co-cultured with a strain of V. cholerae O139 Bengal within a biofilm on the same chitin surface immersed in seawater, and O1-to-O139 transformants were obtained. Serogroup conversion of the O1 recipient by the O139 donor was demonstrated by comparative genomic hybridization, biochemical and serological characterization of the O-antigenic determinant, and resistance of O1-to-O139 transformants to bacteriolysis by a virulent O1-specific phage. Serogroup conversion was shown to have occurred as a single-step exchange of large fragments of DNA. Crossovers were localized to regions of homology common to other V. cholerae serogroups that flank serogroup-specific encoding sequences. This result and the successful serogroup conversion of an O1 strain by O37 genomic DNA indicate that chitin-induced natural transformation might be a common mechanism for serogroup conversion in aquatic habitats and for the emergence of V. cholerae variants that are better adapted for survival in environmental niches or more pathogenic for humans.


Subject(s)
Fresh Water/microbiology , Transformation, Bacterial/immunology , Vibrio cholerae/immunology , Water Microbiology , Adaptation, Physiological/genetics , Adaptation, Physiological/immunology , Agglutination Tests , Animals , Biofilms , Chitin/metabolism , Copepoda/metabolism , Copepoda/microbiology , DNA, Bacterial/analysis , Gene Expression Regulation, Bacterial , Genes, Bacterial/genetics , Genes, Bacterial/immunology , Nucleic Acid Hybridization , O Antigens/biosynthesis , Serotyping , Transformation, Bacterial/genetics , Vibrio cholerae/genetics , Vibrio cholerae/ultrastructure , Water Supply
6.
J Infect Dis ; 194(3): 331-40, 2006 Aug 01.
Article in English | MEDLINE | ID: mdl-16826481

ABSTRACT

Recent data indicate that the human pathogen group B Streptococcus (GBS) produces pilus-like structures encoded in genomic islands with similar organization to pathogenicity islands. On the basis of the amino acid sequence of their protein components, 3 different types of pili have been identified in GBS, at least 1 of which is present in all isolates. We recently demonstrated that recombinant pilus proteins protect mice from lethal challenge with GBS and are thus potential vaccine candidates. Here, we show that GBS pilin island 1, transferred into the nonpathogenic microorganism Lactococcus lactis, leads to pilus assembly. We also show that systemically or mucosally delivered Lactococcus expressing pilin island 1 protects mice from challenge with GBS isolates carrying pilus 1. Furthermore, lactococci engineered to express hybrid pili containing GBS pilus 1 and pilus 2 components confer protection against strains expressing either of the 2 pilus types. These data pave the way to the design of pilus-based, multivalent live vaccines against streptococcal pathogens.


Subject(s)
Fimbriae Proteins/immunology , Lactococcus lactis/immunology , Streptococcal Infections/prevention & control , Streptococcal Vaccines/immunology , Streptococcus agalactiae/immunology , Animals , Female , Fimbriae Proteins/biosynthesis , Fimbriae Proteins/genetics , Fimbriae Proteins/isolation & purification , Fimbriae, Bacterial/genetics , Fimbriae, Bacterial/immunology , Genomic Islands , Lactococcus lactis/genetics , Mice , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification , Streptococcal Infections/immunology , Streptococcal Infections/microbiology , Streptococcal Vaccines/genetics , Streptococcal Vaccines/pharmacology , Streptococcus agalactiae/genetics , Transformation, Bacterial/genetics , Transformation, Bacterial/immunology
7.
Immunity ; 5(1): 63-72, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8758895

ABSTRACT

Using expression cloning, we have identified an H2-M3-restricted epitope of the intracellular bacterial pathogen Listeria monocytogenes. Picomolar concentrations of an amino-terminal N-formylated hexapeptide, fMIGWII, targeted cells for lysis by CD8+ cytotoxic T cells, while the nonformylated peptide was approximately 100-fold less active. The sequence of the 185 aa protein source of this epitope predicts a transmembrane protein that retains its N terminus and assumes an N(out)-C(in) topology. This membrane orientation offers an explanation for the protection of the epitope from deformylases present in the bacterial cell and suggests an explanation for the ability of phagocytes to present H2-M3-restricted bacterial epitopes via a vacuolar TAP-independent mechanism.


Subject(s)
Antigen Presentation , Antigens, Bacterial/isolation & purification , Bacterial Proteins/isolation & purification , Epitopes/isolation & purification , H-2 Antigens/immunology , Listeria monocytogenes/immunology , Alleles , Amino Acid Sequence , Animals , Antigen Presentation/genetics , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Base Sequence , Cytotoxicity, Immunologic/genetics , Epitopes/genetics , Epitopes/immunology , Gene Library , H-2 Antigens/genetics , Listeria monocytogenes/genetics , Membrane Proteins/genetics , Membrane Proteins/immunology , Membrane Proteins/isolation & purification , Mice , Mice, Inbred C57BL , Molecular Sequence Data , T-Lymphocytes, Cytotoxic/immunology , Transformation, Bacterial/immunology
8.
Article in Russian | MEDLINE | ID: mdl-7941851

ABSTRACT

The main protective antigen of the causative agent of plague is capsular antigen F1. The preparations of this antigen isolated from Y.pestis strain EV are characterized by a high content of polysaccharide chains of endotoxins. This can be avoided by using R-variants of bacteria as producers. In this work the comparative study of the preparations of antigen F1 obtained from Y.pestis strain EV, Escherichia coli producer strain HB101 pFS1 with the complete structure of LPS and Salmonella minnesota producer strain Re595 pFS1 with maximally reduced LPS has been made. As revealed in this study, the physico-chemical properties of these preparations (the isoelectric point, electrophoretic mobility, the molecular weight of subunits) are identical. The preparation of antigen F1 obtained from S.minnesota has been found to give the highest yield and to have the lowest content of polysaccharide admixtures. This preparation has proved to possess the maximal protective potency, which may be linked with the adjuvant and immunogenic activity of microadmixtures of glycolipid Re, contained in F1.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Capsules/immunology , Lipopolysaccharides/immunology , Yersinia pestis/immunology , Animals , Antigens, Bacterial/analysis , Antigens, Bacterial/isolation & purification , Bacterial Capsules/analysis , Bacterial Capsules/isolation & purification , Escherichia coli/genetics , Escherichia coli/immunology , Female , Male , Mice , Plague/immunology , Plague/prevention & control , Plasmids/immunology , Random Allocation , Recombination, Genetic/immunology , Salmonella/genetics , Salmonella/immunology , Transformation, Bacterial/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...